{"id":2796,"date":"2015-09-25T10:03:16","date_gmt":"2015-09-25T08:03:16","guid":{"rendered":"https:\/\/www.farmaindustria.es\/web_en\/?p=2796"},"modified":"2015-09-25T10:03:16","modified_gmt":"2015-09-25T08:03:16","slug":"the-pharmaceutical-industry-invested-950me-in-rd-in-2014","status":"publish","type":"post","link":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/","title":{"rendered":"The Pharmaceutical industry invested 950M\u20ac in R&amp;D in 2014"},"content":{"rendered":"<p><strong>Madrid, September 24th 2015<\/strong>.- 950 M\u20ac was the total amount allocated by the Spanish based Pharmaceutical industry towards R&amp;D activities in 2014, according to Farmaindustria\u2019s Survey conducted on its members.<\/p>\n<p>In this way, R&amp;D investment has grown again by 2.4%, after three consecutive years of falls, which were mainly due to the hefty adjustments made during the economic crisis and where the Pharmaceutical market suffered noticeably.<\/p>\n<p><a href=\"https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/09\/Farmaindustria_RD2015.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter  wp-image-2797\" src=\"https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/09\/Farmaindustria_RD2015.jpg\" alt=\"Farmaindustria_R&amp;D2015\" width=\"697\" height=\"313\" srcset=\"https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/09\/Farmaindustria_RD2015-300x136.jpg 300w, https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/09\/Farmaindustria_RD2015-50x23.jpg 50w\" sizes=\"auto, (max-width: 697px) 100vw, 697px\" \/><\/a><\/p>\n<p>It is worth highlighting that 382 M\u20ac of the invested money was allocated to research contracts with hospitals, universities and research centers, which is normally known as extramural R&amp;D. This budgeted item has increased by almost one and a half percentage points compared with 2013, representing 41% of the total R&amp;D investments of the pharmaceutical industry. These collaborations are fundamental for the research of new medicines, as well as for the scientific developments of public organisms and institutions. In this regard, notwithstanding the crisis suffered during recent years, investment in this area has remained constant during the last decade, which proves how important extramural R&amp;D is for the Spanish based pharmaceutical industry.<\/p>\n<p>On the other hand, intramural research reached a value of 568 M\u20ac, around 59% of total investments. The biggest shares of these investments were undertaken in Catalonia (45%) and Madrid (43%); the remaining 12% was undertaken in other Spanish Regions or abroad.<\/p>\n<p>Where expenditure items invested in R&amp;D are concerned, the most important one was allocated to clinical research &#8211; for slightly over 486 M\u20ac; where Spain still holds great opportunities for development. Additionally, basic research, key for scientific development, took second place with an investment of more than 126 M\u20ac.<\/p>\n<p>Finally, the Survey confirms the rise in biotechnological research, given that last year the Pharmaceutical industry invested 224 M\u20ac in this kind of research, which increased by more than 12% compared to 2013. Biotechnological research investments account for 23.6% of pharmaceutical R&amp;D in Spain.<\/p>\n<p>With these above figures, the Pharmaceutical industry consolidates its leadership in R&amp;D in Spain.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Madrid, September 24th 2015.- 950 M\u20ac was the total amount allocated by the Spanish based Pharmaceutical industry towards R&amp;D activities in 2014, according to Farmaindustria\u2019s Survey conducted on its members. In this way, R&amp;D investment has grown again by 2.4%, after three consecutive years of falls, which were mainly due to the hefty adjustments made  <a href=\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/\" class=\"read-more\">&hellip;<\/a><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-2796","post","type-post","status-publish","format-standard","hentry","tema-laboratorios","tema-investigacion-y-desarrollo","geografica-espana"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The Pharmaceutical industry invested 950M\u20ac in R&amp;D in 2014 - FarmaIndustria<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Pharmaceutical industry invested 950M\u20ac in R&amp;D in 2014 - FarmaIndustria\" \/>\n<meta property=\"og:description\" content=\"Madrid, September 24th 2015.- 950 M\u20ac was the total amount allocated by the Spanish based Pharmaceutical industry towards R&amp;D activities in 2014, according to Farmaindustria\u2019s Survey conducted on its members. In this way, R&amp;D investment has grown again by 2.4%, after three consecutive years of falls, which were mainly due to the hefty adjustments made &hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/\" \/>\n<meta property=\"og:site_name\" content=\"FarmaIndustria\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/pages\/Farmaindustria\/730634013647836?ref=hl\" \/>\n<meta property=\"article:published_time\" content=\"2015-09-25T08:03:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/09\/Farmaindustria_RD2015.jpg\" \/>\n<meta name=\"author\" content=\"Nathalie Rooney\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@FarmaIndustria\" \/>\n<meta name=\"twitter:site\" content=\"@FarmaIndustria\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nathalie Rooney\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/\"},\"author\":{\"name\":\"Nathalie Rooney\",\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/#\/schema\/person\/0d4299f2aea1d36b54db40fc10230603\"},\"headline\":\"The Pharmaceutical industry invested 950M\u20ac in R&amp;D in 2014\",\"datePublished\":\"2015-09-25T08:03:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/\"},\"wordCount\":337,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/09\/Farmaindustria_RD2015.jpg\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/\",\"url\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/\",\"name\":\"The Pharmaceutical industry invested 950M\u20ac in R&amp;D in 2014 - FarmaIndustria\",\"isPartOf\":{\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/09\/Farmaindustria_RD2015.jpg\",\"datePublished\":\"2015-09-25T08:03:16+00:00\",\"author\":{\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/#\/schema\/person\/0d4299f2aea1d36b54db40fc10230603\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/#primaryimage\",\"url\":\"https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/09\/Farmaindustria_RD2015.jpg\",\"contentUrl\":\"https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/09\/Farmaindustria_RD2015.jpg\",\"width\":798,\"height\":362},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.farmaindustria.es\/web_en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Pharmaceutical industry invested 950M\u20ac in R&amp;D in 2014\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/#website\",\"url\":\"https:\/\/www.farmaindustria.es\/web_en\/\",\"name\":\"FarmaIndustria\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.farmaindustria.es\/web_en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.farmaindustria.es\/web_en\/#\/schema\/person\/0d4299f2aea1d36b54db40fc10230603\",\"name\":\"Nathalie Rooney\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/a544889d96ab667147c2dddf3cdd9b4cdf2a0044511df45b193d666e09d8b3db?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a544889d96ab667147c2dddf3cdd9b4cdf2a0044511df45b193d666e09d8b3db?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a544889d96ab667147c2dddf3cdd9b4cdf2a0044511df45b193d666e09d8b3db?s=96&d=mm&r=g\",\"caption\":\"Nathalie Rooney\"},\"url\":\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/author\/franfranco\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Pharmaceutical industry invested 950M\u20ac in R&amp;D in 2014 - FarmaIndustria","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/","og_locale":"en_US","og_type":"article","og_title":"The Pharmaceutical industry invested 950M\u20ac in R&amp;D in 2014 - FarmaIndustria","og_description":"Madrid, September 24th 2015.- 950 M\u20ac was the total amount allocated by the Spanish based Pharmaceutical industry towards R&amp;D activities in 2014, according to Farmaindustria\u2019s Survey conducted on its members. In this way, R&amp;D investment has grown again by 2.4%, after three consecutive years of falls, which were mainly due to the hefty adjustments made &hellip;","og_url":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/","og_site_name":"FarmaIndustria","article_publisher":"https:\/\/www.facebook.com\/pages\/Farmaindustria\/730634013647836?ref=hl","article_published_time":"2015-09-25T08:03:16+00:00","og_image":[{"url":"https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/09\/Farmaindustria_RD2015.jpg","type":"","width":"","height":""}],"author":"Nathalie Rooney","twitter_card":"summary_large_image","twitter_creator":"@FarmaIndustria","twitter_site":"@FarmaIndustria","twitter_misc":{"Written by":"Nathalie Rooney","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/#article","isPartOf":{"@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/"},"author":{"name":"Nathalie Rooney","@id":"https:\/\/www.farmaindustria.es\/web_en\/#\/schema\/person\/0d4299f2aea1d36b54db40fc10230603"},"headline":"The Pharmaceutical industry invested 950M\u20ac in R&amp;D in 2014","datePublished":"2015-09-25T08:03:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/"},"wordCount":337,"commentCount":0,"image":{"@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/#primaryimage"},"thumbnailUrl":"https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/09\/Farmaindustria_RD2015.jpg","inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/","url":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/","name":"The Pharmaceutical industry invested 950M\u20ac in R&amp;D in 2014 - FarmaIndustria","isPartOf":{"@id":"https:\/\/www.farmaindustria.es\/web_en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/#primaryimage"},"image":{"@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/#primaryimage"},"thumbnailUrl":"https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/09\/Farmaindustria_RD2015.jpg","datePublished":"2015-09-25T08:03:16+00:00","author":{"@id":"https:\/\/www.farmaindustria.es\/web_en\/#\/schema\/person\/0d4299f2aea1d36b54db40fc10230603"},"breadcrumb":{"@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/#primaryimage","url":"https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/09\/Farmaindustria_RD2015.jpg","contentUrl":"https:\/\/www.farmaindustria.es\/web_en\/wp-content\/uploads\/sites\/3\/2015\/09\/Farmaindustria_RD2015.jpg","width":798,"height":362},{"@type":"BreadcrumbList","@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2015\/09\/25\/the-pharmaceutical-industry-invested-950me-in-rd-in-2014\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.farmaindustria.es\/web_en\/"},{"@type":"ListItem","position":2,"name":"The Pharmaceutical industry invested 950M\u20ac in R&amp;D in 2014"}]},{"@type":"WebSite","@id":"https:\/\/www.farmaindustria.es\/web_en\/#website","url":"https:\/\/www.farmaindustria.es\/web_en\/","name":"FarmaIndustria","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.farmaindustria.es\/web_en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.farmaindustria.es\/web_en\/#\/schema\/person\/0d4299f2aea1d36b54db40fc10230603","name":"Nathalie Rooney","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a544889d96ab667147c2dddf3cdd9b4cdf2a0044511df45b193d666e09d8b3db?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a544889d96ab667147c2dddf3cdd9b4cdf2a0044511df45b193d666e09d8b3db?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a544889d96ab667147c2dddf3cdd9b4cdf2a0044511df45b193d666e09d8b3db?s=96&d=mm&r=g","caption":"Nathalie Rooney"},"url":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/author\/franfranco\/"}]}},"_links":{"self":[{"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/posts\/2796","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/comments?post=2796"}],"version-history":[{"count":1,"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/posts\/2796\/revisions"}],"predecessor-version":[{"id":2798,"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/posts\/2796\/revisions\/2798"}],"wp:attachment":[{"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/media?parent=2796"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}